Press Release

SOUTHPORT, N.C. (September 6, 2017) - Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities in biopharmaceuticals, announced today that it has selected DBA Italia S.r.l. to distribute its products in Italy. DBA Italia has a 34-year track record, serving customers in biomedical research, immunology, biochemistry, molecular biology, microbiology,...

SOUTHPORT, N.C. (June 19, 2017) -  Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities in biopharmaceuticals, announced today that it has selected Bio-Connect BV to distribute the company’s products in The Netherlands, Belgium and Luxembourg.

“Bio-Connect BV is a dynamic company with excellent coverage of the life science res...

BURLINGAME, Calif. (October 20, 2016) -  Maravai LifeSciences, a transformative company in the life science research market, announced today that it has acquired Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities in biopharmaeuticals. The acquisition fits with Maravai LifeSciences’ goal of creating a...

SOUTHPORT, N.C. (May 12, 2015) - Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities in biopharmaceuticals, announced today a new Antibody Affinity Extraction™ (AAE) method for the detection of individual proteins in biotherapeutic products. A superior alternative to 2D western blot methods, AAE is estimated to be 100 times more sensit...

Contacts for the media

Jennifer Dahlgren 
Dahlgren Communications 
Phone: (530) 263-6817 
Email: dahlgrenpr@comcast.net

David Weber, Chief Commercial Officer
Maravai LifeSciences 
Phone: (650) 697-3600 
Email: david.weber@maravai.com